Skip to main content
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Inclusion, Diversity, Equity, Anti-racism, & Social Justice (IDEAS)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Inclusion, Diversity, Equity, Anti-racism, & Social Justice (IDEAS)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

User menu

  • Subscribe
  • My Alerts
  • Log in

Search

  • Advanced search
Neurology
Home
The most widely read and highly cited peer-reviewed neurology journal
  • Subscribe
  • My Alerts
  • Log in
Site Logo
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

Share

March 04, 2008; 70 (10) Articles

Bevacizumab for recurrent malignant gliomas

Efficacy, toxicity, and patterns of recurrence

A. D. Norden, G. S. Young, K. Setayesh, A. Muzikansky, R. Klufas, G. L. Ross, A. S. Ciampa, L. G. Ebbeling, B. Levy, J. Drappatz, S. Kesari, P. Y. Wen
First published March 3, 2008, DOI: https://doi.org/10.1212/01.wnl.0000304121.57857.38
A. D. Norden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
G. S. Young
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
K. Setayesh
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A. Muzikansky
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
R. Klufas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
G. L. Ross
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A. S. Ciampa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
L. G. Ebbeling
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
B. Levy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J. Drappatz
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
S. Kesari
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
P. Y. Wen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Full PDF
Citation
Bevacizumab for recurrent malignant gliomas
Efficacy, toxicity, and patterns of recurrence
A. D. Norden, G. S. Young, K. Setayesh, A. Muzikansky, R. Klufas, G. L. Ross, A. S. Ciampa, L. G. Ebbeling, B. Levy, J. Drappatz, S. Kesari, P. Y. Wen
Neurology Mar 2008, 70 (10) 779-787; DOI: 10.1212/01.wnl.0000304121.57857.38

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
1943

Share

  • Article
  • Figures & Data
  • Info & Disclosures
  • CME Course
Loading

Article Information

vol. 70 no. 10 779-787
DOI: 
https://doi.org/10.1212/01.wnl.0000304121.57857.38
PubMed: 
18316689

Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • First Published March 3, 2008.

Copyright & Usage: 
© 2008

Author Disclosures

    1. A. D. Norden, MD,
    2. G. S. Young, MD,
    3. K. Setayesh, MA,
    4. A. Muzikansky, MA,
    5. R. Klufas, MD,
    6. G. L. Ross, MD,
    7. A. S. Ciampa, NP,
    8. L. G. Ebbeling, BA,
    9. B. Levy, BA,
    10. J. Drappatz, MD,
    11. S. Kesari, MD, PhD and
    12. P. Y. Wen, MD
  1. A. D. Norden, MD,
  2. G. S. Young, MD,
  3. K. Setayesh, MA,
  4. A. Muzikansky, MA,
  5. R. Klufas, MD,
  6. G. L. Ross, MD,
  7. A. S. Ciampa, NP,
  8. L. G. Ebbeling, BA,
  9. B. Levy, BA,
  10. J. Drappatz, MD,
  11. S. Kesari, MD, PhD and
  12. P. Y. Wen, MD
  1. From the Division of Cancer Neurology (A.D.N., A.S.C., L.G.E., B.L., J.D., S.K., P.Y.W.), Department of Neurology, Brigham and Women's Hospital and Center For Neuro-Oncology, Dana-Farber/Brigham and Women's Cancer Center and Harvard Medical School; Brigham and Women's Hospital Department of Radiology and Harvard Medical School (G.S.Y., K.S., R.K., G.L.R.); and Massachusetts General Hospital Biostatistics Center (A.M.), Boston.
  1. Address correspondence and reprint requests to Dr Norden, Dana-Farber/Brigham and Women's Cancer Center and Harvard Medical School, SW430B, 44 Binney St., Boston, MA 02115 anorden{at}partners.org
View Full Text

Article usage

Article usage: March 2008 to December 2022

AbstractFullPdfSource
Mar 200850787208Highwire
Apr 20082023176Highwire
May 20083324769Highwire
Jun 20081371650Highwire
Jul 20081253349Highwire
Aug 2008794544Highwire
Sep 20081087263Highwire
Oct 20081367669Highwire
Nov 20081053761Highwire
Dec 2008933032Highwire
Jan 20091015443Highwire
Feb 20091102835Highwire
Mar 20091482948Highwire
Apr 2009953343Highwire
May 2009902729Highwire
Jun 20091082629Highwire
Jul 20091283336Highwire
Aug 2009832221Highwire
Sep 2009751727Highwire
Oct 20091303331Highwire
Nov 20091293143Highwire
Dec 20091252226Highwire
Jan 20101141414Highwire
Feb 2010832122Highwire
Mar 2010812129Highwire
Apr 20101052426Highwire
May 2010981917Highwire
Jun 2010781916Highwire
Jul 201084823Highwire
Aug 2010881120Highwire
Sep 2010751617Highwire
Oct 2010852028Highwire
Nov 20103637Highwire
Dec 2010862712Highwire
Jan 2011833616Highwire
Feb 2011891611Highwire
Mar 2011102710Highwire
Apr 2011671614Highwire
May 2011642520Highwire
Jun 2011681413Highwire
Jul 20115089Highwire
Aug 2011622213Highwire
Sep 2011902318Highwire
Oct 20119689Highwire
Nov 20116276Highwire
Dec 20114878Highwire
Jan 201250106Highwire
Feb 2012621015Highwire
Mar 20126665Highwire
Apr 20126564Highwire
May 201279126Highwire
Jun 201269912Highwire
Jul 201267149Highwire
Aug 2012741215Highwire
Sep 20127878Highwire
Oct 201289173Highwire
Nov 20126697Highwire
Dec 2012551411Highwire
Jan 20138984Highwire
Feb 20136552Highwire
Mar 201356101Highwire
Apr 201355211Highwire
May 2013571511Highwire
Jun 20135092Highwire
Jul 201366143Highwire
Aug 201347123Highwire
Sep 2013631612Highwire
Oct 2013791010Highwire
Nov 20137363Highwire
Dec 201357106Highwire
Jan 20146576Highwire
Feb 201474115Highwire
Mar 2014621012Highwire
Apr 20147033Highwire
May 201466118Highwire
Jun 201410779Highwire
Jul 201410576Highwire
Aug 20145878Highwire
Sep 20143073Highwire
Oct 20145553Highwire
Nov 20145166Highwire
Dec 20145313Highwire
Jan 20155911Highwire
Feb 20156842Highwire
Mar 20154955Highwire
Apr 20155945Highwire
May 20154253Highwire
Jun 20155671Highwire
Jul 20156982Highwire
Aug 20153653Highwire
Sep 20157040Highwire
Oct 20154877Highwire
Nov 20156186Highwire
Dec 20155233Highwire
Jan 20164631Highwire
Feb 20164298Highwire
Mar 20165834Highwire
Apr 20164042Highwire
May 20163632Highwire
Jun 20163510Highwire
Jul 20165165Highwire
Aug 20164732Highwire
Sep 20163732Highwire
Oct 20166224Highwire
Nov 20165521Highwire
Dec 20168022Highwire
Jan 20175710Highwire
Feb 20174053Highwire
Mar 20174883Highwire
Apr 20175462Highwire
May 20175120Highwire
Jun 20173911Highwire
Jul 20175202Highwire
Aug 20176555Highwire
Sep 20174423Highwire
Oct 20175210Highwire
Nov 20173413Highwire
Dec 20174022Highwire
Jan 20188463Highwire
Feb 20185751Highwire
Mar 201877126Highwire
Apr 201883103Highwire
May 20186331Highwire
Jun 20184923Highwire
Jul 20183732Highwire
Aug 20185150Highwire
Sep 20184843Highwire
Oct 20185742Highwire
Nov 20186951Highwire
Dec 20185661Highwire
Jan 20196472Highwire
Feb 20195143Highwire
Mar 20195942Highwire
Apr 20193432Highwire
May 20193951Highwire
Jun 20192392Highwire
Jul 20195750Highwire
Aug 2019831142Highwire
Sep 2019145135Highwire
Oct 201991103Highwire
Nov 20197961Highwire
Dec 20194862Highwire
Jan 20203592Highwire
Feb 202074116Highwire
Mar 20205483Highwire
Apr 20205222Highwire
May 20205020Highwire
Jun 20203993Highwire
Jul 20204541Highwire
Aug 20204821Highwire
Sep 20206093Highwire
Oct 20204951Highwire
Nov 20205940Highwire
Dec 20204421Highwire
Jan 20214664Highwire
Feb 202142112Highwire
Mar 20217552Highwire
Apr 20217010Highwire
May 20216871Highwire
Jun 20215051Highwire
Jul 20215260Highwire
Aug 20216981Highwire
Sep 20215770Highwire
Oct 20216651Highwire
Nov 20214963Highwire
Dec 20213762Highwire
Jan 20222851Highwire
Feb 20227141Highwire
Mar 20228030Highwire
Apr 20224921Highwire
May 20227262Highwire
Jun 20223231Highwire
Jul 20225171Highwire
Aug 20224361Highwire
Sep 20227562Highwire
Oct 20227743Highwire
Nov 202210290Highwire
Dec 202281113Highwire

Cited By...

  • 638 Citations
  • Google Scholar

Letters: Rapid online correspondence

  • Bevacizumab for recurrent malignant gliomas: Efficacy, toxicity, and patterns of recurrence
    • Marc C. Chamberlain, University of Washington, Seattle Cancer Care Alliance, 825 Eastlake Ave E, POB 19023, MS G4940, Seattle, WA 98109-1023chambemc@u.washington.edu
    Submitted June 04, 2008
  • Bevacizumab for recurrent malignant gliomas: Efficacy, toxicity, and patterns of recurrence
    • Maciej M. Mrugala, University of Washington/Fred Hutchinson Cancer Research Center, 1959 NE Pacific Street, Seattle, WA 98195mmrugala@u.washington.edu
    Submitted June 04, 2008
  • Reply from the Authors
    • Andrew D Norden, Brigham and Women's Hospital, 44 Binney St, Boston, MA 02115anorden@partners.org
    • Geoffrey S. Young, Patrick Y. Wen
    Submitted June 04, 2008
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
    • Abstract
    • Glossary
    • METHODS
    • RESULTS
    • DISCUSSION
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Disclosures
  • CME Course

More Online

CME Course

Hemiplegic Migraine Associated With PRRT2 Variations A Clinical and Genetic Study

Dr. Robert Shapiro and Dr. Amynah Pradhan

► Watch

Topics Discussed

  • Primary brain tumor
  • MRI
  • Chemotherapy-tumor
  • Volumetric MRI

Alert Me

  • Alert me when eletters are published
Neurology: 100 (5)

Articles

  • Ahead of Print
  • Current Issue
  • Past Issues
  • Popular Articles
  • Translations

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Activate a Subscription
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Education
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology | Print ISSN:0028-3878
Online ISSN:1526-632X

© 2023 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise